Resonance Health, a healthcare technology and services company, engages in the development and commercialisation of magnetic resonance imaging (MRI) related technology primarily in Australia.
The company’s core product is FerriScan, a non-invasive liver diagnostic product used for the measurement of iron levels in the liver. Its FerriScan also provides a range of value added services for clinical trials using imaging end points.
The company is also developing imaging tools for the non-invasive assessment of liver fat and liver fibrosis to address clinical need for patients with fatty liver disease and viral hepatitis.